These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32845650)

  • 1. Crown Ether Nanovesicles (Crownsomes) Repositioned Phenytoin for Healing of Corneal Ulcers.
    Mahmoud DB; Afifi SA; El Sayed NS
    Mol Pharm; 2020 Oct; 17(10):3952-3965. PubMed ID: 32845650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crown Ethers: Novel Permeability Enhancers for Ocular Drug Delivery?
    Morrison PWJ; Porfiryeva NN; Chahal S; Salakhov IA; Lacourt C; Semina II; Moustafine RI; Khutoryanskiy VV
    Mol Pharm; 2017 Oct; 14(10):3528-3538. PubMed ID: 28825493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro/in vivo evaluations of novel ocular micelle formulations of hesperetin with glycyrrhizin as a nanocarrier.
    Zhang F; Chen H; Lan J; Song K; Wu X
    Exp Eye Res; 2021 Jan; 202():108313. PubMed ID: 33080302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid thermosensitive-mucoadhesive
    Fathalla Z; Mustafa WW; Abdelkader H; Moharram H; Sabry AM; Alany RG
    Drug Deliv; 2022 Dec; 29(1):374-385. PubMed ID: 35068268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of autologous serum eye drops on corneal wound healing after superficial keratectomy in rabbits.
    Akyol-Salman I
    Cornea; 2006 Dec; 25(10):1178-81. PubMed ID: 17172894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability.
    Liu R; Liu Z; Zhang C; Zhang B
    J Pharm Sci; 2012 Oct; 101(10):3833-44. PubMed ID: 22767401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization:
    Ma Y; Yang J; Zhang Y; Zheng C; Liang Z; Lu P; Song F; Wang Y; Zhang J
    Drug Deliv; 2022 Dec; 29(1):111-127. PubMed ID: 34964414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation.
    Dai Y; Zhou R; Liu L; Lu Y; Qi J; Wu W
    Int J Nanomedicine; 2013; 8():1921-33. PubMed ID: 23690687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
    Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
    Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pilot study of a new matrix therapy agent (RGTA OTR4120) in treatment-resistant corneal ulcers and corneal dystrophy].
    Chebbi CK; Kichenin K; Amar N; Nourry H; Warnet JM; Barritault D; Baudouin C
    J Fr Ophtalmol; 2008 May; 31(5):465-71. PubMed ID: 18641578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies.
    Brignole-Baudouin F; Warnet JM; Barritault D; Baudouin C
    J Fr Ophtalmol; 2013 Nov; 36(9):740-7. PubMed ID: 23958066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled sodium alginate polymannuronate nanoparticles for synergistic treatment of ophthalmic infection and inflammation: Preparation optimization and in vitro/vivo evaluation.
    Datta N; Jinan T; Wong SY; Chakravarty S; Li X; Anwar I; Arafat MT
    Int J Biol Macromol; 2024 Mar; 262(Pt 2):130038. PubMed ID: 38336323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive eyedrops containing platelet lysate for the treatment of corneal ulcers.
    Sandri G; Bonferoni MC; Rossi S; Ferrari F; Mori M; Del Fante C; Perotti C; Caramella C
    Int J Pharm; 2012 Apr; 426(1-2):1-6. PubMed ID: 22248667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment.
    Liu S; Han X; Liu H; Zhao Y; Li H; D Rupenthal I; Lv Z; Chen Y; Yang F; Ping Q; Pan Y; Hou D
    Drug Deliv; 2020 Dec; 27(1):652-661. PubMed ID: 32347126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport mechanism of chitosan-N-acetylcysteine, chitosan oligosaccharides or carboxymethyl chitosan decorated coumarin-6 loaded nanostructured lipid carriers across the rabbit ocular.
    Li J; Tan G; Cheng B; Liu D; Pan W
    Eur J Pharm Biopharm; 2017 Nov; 120():89-97. PubMed ID: 28867370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
    Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
    J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for management of glaucoma: Formulation, characterization and pharmacodynamic study.
    Dubey V; Mohan P; Dangi JS; Kesavan K
    Int J Biol Macromol; 2020 Jun; 152():1224-1232. PubMed ID: 31751741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment.
    Abdelbary AA; Abd-Elsalam WH; Al-Mahallawi AM
    Int J Pharm; 2016 Nov; 513(1-2):688-696. PubMed ID: 27717916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.
    Wang J; Zhao F; Liu R; Chen J; Zhang Q; Lao R; Wang Z; Jin X; Liu C
    Int J Nanomedicine; 2017; 12():8115-8127. PubMed ID: 29158673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.